Kinea Oportunidades (Brazil) Fund

KORE11 Fund   83.66  1.74  2.12%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak
Kinea Oportunidades is trading at 83.66 as of the 25th of November 2024, a 2.12% increase since the beginning of the trading day. The fund's open price was 81.92. Kinea Oportunidades has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Kinea Oportunidades Real are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2022 and ending today, the 25th of November 2024. Click here to learn more.

Kinea Oportunidades Real Risk Profiles

Although Kinea Oportunidades' alpha and beta are two of the key measurements used to evaluate Kinea Oportunidades' performance over the market, the standard measures of volatility play an important role as well.

Kinea Oportunidades Against Markets

Kinea Oportunidades Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kinea Oportunidades fund to make a market-neutral strategy. Peer analysis of Kinea Oportunidades could also be used in its relative valuation, which is a method of valuing Kinea Oportunidades by comparing valuation metrics with similar companies.
 Risk & Return  Correlation
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets